Two companies devoted to consumer products released earnings this week. One makes items used for cleaning, the other makes goods that you can actually eat.

We'll start with the cleaning-item concern. The Clorox Company (CLX), manufacturer of the iconic laundry bleach, issued results for its fiscal second quarter earlier today. At the time of this writing, shares were higher by 2.4% to a quote of $65.26. Volume was strong. The 52-week low for the stock is $59.07 and the 52-week high is $69. The one-year chart is, well ... not that great.

Continue reading Earnings from Clorox and Kellogg

Earnings from Clorox and Kellogg originally appeared on BloggingStocks on Fri, 04 Feb 2011 17:40:00 EST. Please see our terms for use of feeds.

Kimberly-Clark (KMB), a consumer products company that counts Procter & Gamble (PG) as a colleague, is a very interesting stock for two reasons. First, it's not too far away from its 52-week high. Second, it's trading with an extremely nice dividend yield attached. Those two elements can't help but make an investor take notice.

In fact, speaking about the dividend yield, according to the company's Q4 earnings results, management has increased the quarterly payout by 6% to 70 cents per share. Excellent news. Based on Tuesday's closing price of $65.61, a quote that found the stock up by 2.6% on significant volume, the yield on the shares is now roughly 4.3%.

Continue reading Should We Be Bullish on Kimberly-Clark?

Should We Be Bullish on Kimberly-Clark? originally appeared on BloggingStocks on Wed, 26 Jan 2011 09:30:00 EST. Please see our terms for use of feeds.

Continue reading Kimberly-Clark Earnings: Time to Buy or Sell?

Kimberly-Clark Earnings: Time to Buy or Sell? originally appeared on BloggingStocks on Wed, 27 Oct 2010 09:30:00 EST. Please see our terms for use of feeds.

Procter & Gamble (PG) isn't in the green. At the time of this writing, shares of the consumer concern were flat. They were off by a mere nine pennies to $60.31. Perhaps they'll end up in the green by the end of the day, who knows, but one thing's for sure: if you own shares of this one, you're having one heck of a boring Monday.

And you might be bored by something else. According to TheFly, guidance for the full fiscal year hasn't been changed. Management continues to expect the bottom line to come in somewhere between $3.91 per share and $4.01 per share.

Continue reading Procter & Gamble's Dull Price Action

Procter & Gamble's Dull Price Action originally appeared on BloggingStocks on Mon, 13 Sep 2010 14:20:00 EST. Please see our terms for use of feeds.

Continue reading Clorox Flat on Earnings News

Clorox Flat on Earnings News originally appeared on BloggingStocks on Tue, 03 Aug 2010 17:40:00 EST. Please see our terms for use of feeds.

Continue reading Procter & Gamble Sold on Earnings News -- Don't Listen to the Bears!

Procter & Gamble Sold on Earnings News -- Don't Listen to the Bears! originally appeared on BloggingStocks on Tue, 03 Aug 2010 15:30:00 EST. Please see our terms for use of feeds.

The markets are up today, but that doesn't seem to be helping The Clorox Company (CLX). At the time of this writing, shares were fighting the good fight between red-and-green status: they were down 0.2% right after being slightly higher by the same amount during the moments it took me to complete this sentence.

It's the earnings game, folks; Wall Street was cool to the numbers. According to MarketWatch, net income of $1.16 per share was eight pennies ahead of estimates. That doesn't sound so bad, does it?

Continue reading Is Clorox Okay After Q3 Report?

Is Clorox Okay After Q3 Report? originally appeared on BloggingStocks on Mon, 03 May 2010 16:00:00 EST. Please see our terms for use of feeds.

Kraft Foods Inc. (KFT) issued its fourth-quarter report earlier today. Sales increased over 3%, but organic net revenues were flat. Restructuring initiatives helped to drive a very significant jump in operating income, as well as a nice expansion of the operating margin. Net income from continuing businesses came in at 48 cents per share. Not only did this represent robust growth, but it beat estimates by three pennies, according to our earnings preview.

Management promoted an awesome fact in the release: free cash flow was up over 30% for the full fiscal year. Changes in working capital aided the increase. I like it.

Continue reading Kraft Reports Winning Q4

Kraft Reports Winning Q4 originally appeared on BloggingStocks on Tue, 16 Feb 2010 18:00:00 EST. Please see our terms for use of feeds.

Tupperware (TUP) issued Q4 numbers after the bell on Monday. Sales were higher by 10% once benefits from currency exchange were eliminated. Adjusted earnings per share increased 16% to $1.22. According to Earnings.com, net income came in 18 cents better than the average estimate.

Bravo! Tupperware, which counts Newell Rubbermaid (NWL) and Avon Products (AVP) as colleagues, is also doing well with cash flow. In fact, you'll notice from the release that management is increasing its stock buyback by $200 million.

Continue reading Tupperware Reports Strong Q4

Tupperware Reports Strong Q4 originally appeared on BloggingStocks on Tue, 02 Feb 2010 08:40:00 EST. Please see our terms for use of feeds.

WD-40 (WDFC), whose related stocks include Church & Dwight (CHD) and Clorox (CLX), did a good job of courting earnings growth through efficiency. According to yesterday's post-market release, the consumer products concern saw its bottom line jump 22% to 56 cents per diluted share. According to Earnings.com, that was five pennies better than the expectations of Wall Street's smart guys.

Unfortunately, sales growth was not in the cards. The top line experienced a decrease of 7%. Furthermore, according to Reuters, revenues came in softer than projections. It would have been really nice to see at least a little increase in sales, or perhaps an in-line performance, to go along with the improved bottom line. Wasn't meant to be.

Continue reading WD-40 Tops Q1 Estimates, but Needs Better Sales Growth

WD-40 Tops Q1 Estimates, but Needs Better Sales Growth originally appeared on BloggingStocks on Tue, 12 Jan 2010 08:30:00 EST. Please see our terms for use of feeds.

Del Monte (DLM) had a fine second quarter. Net sales went up by over 6%. Earnings per share more than doubled to 31 cents. Analysts were expecting only 21 cents of per-share profit, according to Earnings.com.

Management seems to be striking a proper balance between pricing strategies and the need for volume growth. That's a tough thing to do, and it can't always be done, but Del Monte is obviously utilizing its brand equity to full advantage. Smart marketing campaigns have helped to highlight the company's trademarks and communicate product value.

Continue reading Del Monte delivers a good second quarter

Del Monte delivers a good second quarter originally appeared on BloggingStocks on Fri, 04 Dec 2009 09:00:00 EST. Please see our terms for use of feeds.

Clorox (NYSE: CLX), a consumer-products business that counts Procter & Gamble (NYSE: PG) and Colgate-Palmolive (NYSE: CL) as related stocks, may have seen a sales drop of 1% in its fiscal first quarter, but that didn't stop it from posting a nice bottom-line growth rate. Clorox made $1.11 per share in Q1, and that represents a 23% increase. What a way to start a new corporate year!

According to Reuters, expectations were for 95 cents per share. That's a wonderful beat. Plus, sales volume went up 1%. Helping to drive things along was a healthy gross margin, as well as the dreaded H1N1 virus. Clorox has done well over the years associating its brand with sanitizing effectiveness, so when a pandemic rears its ugly head, the trademark is prepared to leverage such reputation to drive value.

Continue reading Clorox starts its new year off right

Clorox starts its new year off right originally appeared on BloggingStocks on Mon, 02 Nov 2009 17:15:00 EST. Please see our terms for use of feeds.

Avon Products (NYSE: AVP) had a difficult third quarter. Currency translations helped to drive a 4% decrease in net revenue. Excluding that effect, sales were up 7%. Net income decreased a big 31% to 36 cents per share.

However, according to Reuters, adjusted earnings of 42 cents per share beat analyst projections by two pennies. Such news didn't seem to matter to the market. At the time of this writing, Avon was down 1.9% on significant volume.

Continue reading Avon sold on Q3 news, but think long term

Avon sold on Q3 news, but think long term originally appeared on BloggingStocks on Thu, 29 Oct 2009 16:45:00 EST. Please see our terms for use of feeds.

Kimberly-Clark Corporation (NYSE: KMB), a consumer products entity whose colleagues include Procter & Gamble (NYSE: PG) and Johnson & Johnson (NYSE: JNJ), is up today on third-quarter results. At the time of this writing, my screen was showing shares of Kimberly-Clark higher by a little under 6%.

According to the corporate press release, sales declined 1.7%. Not a great start, but Kimberly-Clark highlighted a better metric: organic sales increased 3%, helped along by price increases. Luckily, sales volume didn't fare too badly; they were essentially flat.

Continue reading Kimberly-Clark high on Q3 data

Kimberly-Clark high on Q3 data originally appeared on BloggingStocks on Thu, 22 Oct 2009 17:00:00 EST. Please see our terms for use of feeds.

Del Monte Foods (NYSE: DLM), a supermarket brand whose colleagues include ConAgra (NYSE: CAG) and Kraft (NYSE: KFT), was way up in afternoon trading. When a stock like Del Monte gains 9% on great volume, you know something big must have happened. Well, it was the company's fiscal Q1 results that made investors want to buy today. After checking over the news, I can honestly say that I see the market's point.

Sales increased 12% during the quarter, and earnings from continuing operations calculated out to 30 cents per share, a huge improvement over the loss observed in the comparable period. According to Earnings.com, Wall Street was only looking for a measly four pennies for the bottom line.

Continue reading Del Monte up big on Q1 data

Del Monte up big on Q1 data originally appeared on BloggingStocks on Thu, 03 Sep 2009 15:00:00 EST. Please see our terms for use of feeds.

H.J. Heinz Company (NYSE: HNZ), a food company that shares space at the supermarket with products from Kraft Foods, Inc. (NYSE: KFT), ConAgra (NYSE: CAG), and Campbell Soup (NYSE: CPB), issued first-quarter data on Thursday. Even though the effect of currency translations continues to put a cloud over the top-line performance, management did end up beating earnings expectations.

Net sales came in flat, and net income was 67 cents per share. Analysts were expecting 5 cents less, according to Earnings.com. Shareholders should be happy about that. When I covered Heinz's last quarter, I noted that expectations were essentially beat by a penny.

Continue reading Heinz wins analyst game in Q1, generates higher level of cash

Heinz wins analyst game in Q1, generates higher level of cash originally appeared on BloggingStocks on Thu, 20 Aug 2009 17:30:00 EST. Please see our terms for use of feeds.

The Clorox Company (NYSE: CLX), a famous supermarket brand similar to companies such as Procter & Gamble (NYSE: PG) and Colgate-Palmolive (NYSE: CL), reported Q4 earnings today. Excluding certain factors, Clorox increased its per-share profit by 18% to $1.35.

The dollar continues to wreak havoc on companies with international exposure (there's a whole lot of them, of course). Including currency translations, Clorox's top line was flat. Without the effect (and excluding the impact of a private-label business that the company exited), sales increased 3%. The company utilized price increases to help offset the tough times. Unfortunately, volume decreased 2% during the quarter.

Continue reading Clorox increases prices -- and profit -- in Q4

Clorox increases prices -- and profit -- in Q4 originally appeared on BloggingStocks on Mon, 03 Aug 2009 18:00:00 EST. Please see our terms for use of feeds.

Everything turned out all right for shareholders. Sales weren't so hot: the top line decreased 3% on dollar pressures. Earnings per share saved the day, coming in at 92 cents, good for a 12% increase. The income amount also beat expectations by a very significant margin. Analysts wanted to see at least 83 cents for per-share profit, according to Earnings.com.

Continue reading Kellogg's Q2 more nutritious than analysts thought

Kellogg's Q2 more nutritious than analysts thought originally appeared on BloggingStocks on Fri, 31 Jul 2009 15:10:00 EST. Please see our terms for use of feeds.

Colgate-Palmolive (NYSE: CL), whose colleagues at the supermarket include companies like Procter & Gamble (NYSE: PG) and Clorox (NYSE: CLX), did all right in the second quarter. Sales were inhibited by currency rates: they dropped by well over 5%. The bottom line, on the other hand, fared a lot better. The company made $1.07 per share compared to 92 cents per share in the year-ago period. However, the previous year's quarter had 6 cents of charges to take into account, so the adjusted earnings in 2008 actually comes out to 98 cents. This makes the growth rate a modest 9%. The market was expecting $1.05 per share according to Earnings.com, so management beat by two pennies.

I was surprised a little by how the stock sold off on Thursday after the earnings report. Shares of Colgate-Palmolive closed down over 5% on very active volume.

Continue reading Colgate-Palmolive beats estimates in Q2

Colgate-Palmolive beats estimates in Q2 originally appeared on BloggingStocks on Fri, 31 Jul 2009 09:00:00 EST. Please see our terms for use of feeds.

"Johnson & Johnson (NYSE: JNJ) has vast holdings, but its strategy is simple: Support a deep pipeline of new drugs and medical devices with an aggressive acquisition strategy and cost controls," notes blue chip investor Richard Moroney.

In his Dow Theory Forecasts, he adds, "And despite the recession, J&J has kept its financial footing, remaining one of the few companies with the top credit rating of AAA." Here's his long term outlook.

"This year the U.S. pharmaceutical market is expected to contract for the first time in 50 years as fewer people visit doctors or start new therapies for chronic conditions.

"Beyond 2009, an economic recovery should reinvigorate J&J, though it is too early to determine whether health-care reform will help or harm the company.

Continue reading Johnson & Johnson (JNJ): A triple A play

Johnson & Johnson (JNJ): A triple A play originally appeared on BloggingStocks on Wed, 29 Jul 2009 15:20:00 EST. Please see our terms for use of feeds.